Editorial: Community series in neurobiological biomarkers for developing novel treatments of substance and non-substance addiction, volume II

Yehong Fang, Yi Liu, Ling Li, Dara G. Ghahremani, Jianhua Chen, Kyoji Okita, Wenbin Guo, Yanhui LiaoFrontiers in Psychiatry 2023 · DOI · OpenAlex

Addiction remains one of the most challenging global health crises, characterized by high relapse rates and a profound lack of "one-size-fits-all" solutions. While the neurocircuitry of reward is well-documented, clinical practice still struggles to predict who will respond to specific treatments. This editorial, published in Frontiers in Psychiatry, synthesizes the second volume of a community series dedicated to identifying neurobiological biomarkers that can bridge the gap between laboratory research and clinical precision medicine.

The collection encompasses 15 diverse studies, including 13 original research papers, a systematic review, and a clinical trial. Together, they explore the neural mechanisms, diagnostic markers, and treatment responses across a spectrum of substance and non-substance addictions.

The Search for Objective Measures

The core challenge in addiction treatment is the absence of objective biomarkers—comparable to a blood glucose test for diabetes—that can diagnose a disorder or predict its severity. The research presented here utilizes a multi-modal approach to find these markers:

  • Neuroimaging: Using resting-state fMRI to measure regional homogeneity (ReHo) and Voxel-Based Morphometry (VBM) to assess gray matter volume (GMV).
  • Electrophysiology: Analyzing EEG components like the P300 to identify vulnerability.
  • Molecular Biology: Sequencing peripheral blood transcriptomes to find signaling pathways associated with long-term substance use.

Key Findings in Substance Addiction

Nicotine: Sex Differences and Cessation Strategies

Research by Wen et al. utilized fMRI to investigate how cigarette smoking affects spontaneous brain activity. They discovered significant sex-dependent differences; specifically, regional homogeneity (ReHo) in the left cerebellum crus1 was negatively correlated with craving scores in men, but not in women. This suggests that the neurobiological "footprint" of nicotine addiction is not uniform across genders, necessitating sex-specific therapeutic approaches.

Furthermore, a study using Ecological Momentary Assessment (EMA) challenged common perceptions of smoking cessation. The results indicated that immediate nicotine reduction led to significantly lower cravings compared to gradual reduction. This provides a robust evidence base for "cold turkey" or rapid-taper strategies in clinical settings.

Alcohol: Risk Factors and Early Detection

Alcohol use disorder remains prevalent across all age groups, including the elderly. Qiu et al. conducted a national community-based survey in China, highlighting a significant prevalence of risky drinking among the "oldest old" (aged 80 and over), suggesting that geriatric addiction requires more clinical attention.

Furthermore, because alcohol dependence has strong genetic determinants, Yu et al. investigated the offspring of parents with alcohol dependence (OPAD). By analyzing the P300 component of EEG, they found distinct differences between OPAD individuals who engaged in risky drinking and those who did not. This suggests that the P300 could serve as a vital biomarker for the early detection of vulnerability in high-risk populations, potentially allowing for preventative interventions.

Opioids and Stimulants

Beyond behavioral markers, the issue explores molecular and pharmacological frontiers. Whole transcriptome sequencing has identified specific signaling pathways (such as GnRH/PI3K/Akt) in peripheral blood that correlate with opioid use. In animal models, researchers compared the effects of d-amphetamine and its prodrug, lisdexamfetamine, finding that the latter provides a steadier dopamine release in the medial prefrontal cortex, leading to improved spatial cognitive performance.

Expanding the Scope: Non-Substance Addictions

A significant contribution of this volume is the inclusion of "non-substance" or behavioral addictions, such as gaming disorder and obesity-related reward dysregulation.

A meta-analysis led by Wang’s group focused on the relationship between obesity and gray matter volume (GMV). The study found that overweight and obese individuals exhibited lower GMV in the left putamen and right precentral gyrus compared to lean controls. These areas are critical for reward processing and sensorimotor control, suggesting a structural basis for the dysregulated eating behaviors seen in obesity that mirrors the neural patterns of substance addiction.

Moving Toward Precision Medicine

The ultimate goal of identifying these biomarkers is "functional validation"—proving that targeting these specific brain regions or genetic pathways leads to better clinical outcomes. While the studies in this volume provide a wealth of new data, several limitations remain:

  • Generalizability: Many studies focused on specific demographics (e.g., the elderly or single-sex cohorts), which may limit the broad application of findings.
  • Diagnostic Tools: There is a pressing need for validated diagnostic tools for emerging issues like Gaming Disorder, particularly in diverse cultural contexts.

In summary, this second special issue advances our understanding of the heterogeneous nature of addiction. By identifying sex-specific responses, genetic vulnerabilities, and structural brain changes, the field moves closer to a future where addiction treatment is as personalized and precise as any other branch of modern medicine.

Summary updated

Abstract

In 2021, we published first special issue on "Neurobiological Biomarkers for Developing Novel Treatments of Substance and Non-substance Addiction" in Frontiers in Psychiatry that covers a wide breath of research, including comprehensive data from the laboratory-based studies, school-based studies, and clinical and intervention studies of addicted patients across multiple fields.These studies highlighted neural mechanisms, detecting biomarkers, diagnosis, and treatment responses of substance and non-substance addiction. In parallel with significant breakthroughs in neuroscience researches, the recent year have seen tremendous advances in several frontiers in substance and non-substance addiction. Thus, it's time for us to summarize the recent progress in this second special issue. A total of 13 original researches, a systematic review and a clinical trial are included in this issue.In the researches on nicotine addiction, Wen et al. investigated the sex-related effects of cigarette smoking on local spontaneous brain activity using regional homogeneity (ReHo) based on resting-state fMRI. They found some sex-dependent differences in spontaneous brain activity, e.g. the ReHo within the left cerebellum crus1 was negatively correlated with craving scores in male but not in female smokers. These findings further our understanding of neural pathophysiology of sex-specific effects of nicotine addiction. Li's group conducted an ecological momentary assessment study to investigate whether the immediate and gradual reduction in nicotine content reduce smoking by reducing cravings. The result showed significantly lower cravings in the immediate vs. gradual nicotine reduction group, which add to the evidence base for reduced nicotine content in cigarettes.Alcohol use disorder is one of the common substance use disorder in the general population. Qiu et al. conducted a national community-based survey to get the prevalence and correlates of risky drinking in Chinese elderly people aged 80 and over and proposed more attention should be given to risky drinking among the oldest old. Alcohol dependence is a chronic mental disease that has both genetic and environmental determinant. As a result, offspring have parents with alcohol dependence, resulting from the high prevalence of alcohol dependence. Yu et al. investigated the personality traits, and P300 component in the offspring of parents with alcohol dependence (OPAD) currently engaged in risky drinking and those not engaged in risky drinking and found P300 differed between OPAD with and without risky drinking. This result indicated that P300 may be used in the early detection of vulnerable OPAD. Given the serious dangers of alcohol dependence, Relationship between obesity and gray matter volume (GMV) alterations is still a concerned point. Wang's group applied an updated meta-analysis of voxel-based GMV studies to compare GMV changes in overweight and obese subjects. The result showed lower GMV in the left putamen and right precentral gyrus, in individuals with overweight and obesity compared to lean controls which suggested an underlying structural basis for reward processing and sensorimotor processing dysregulation in overweight and obese subjects.In summary, the second special issue presented here will further our understanding of substance and non-substance addiction. Our ultimate goal is to understand addiction better and to develop more efficacious and safe treatments for addiction.
BibTeX
@inproceedings{fang2023editorial,
  author = {Yehong Fang and Yi Liu and Ling Li and Dara G. Ghahremani and Jianhua Chen and Kyoji Okita and Wenbin Guo and Yanhui Liao},
  title = {{Editorial: Community series in neurobiological biomarkers for developing novel treatments of substance and non-substance addiction, volume II}},
  booktitle = {Frontiers in Psychiatry},
  year = {2023},
  doi = {10.3389/fpsyt.2023.1134561},
}
Figure